Primer: Medgenics Inc (MDGN US) - Aug 2026
Medgenics, rebranded as Aevi Genomic Medicine in 2016, was a clinical-stage biotechnology company focused on translating genetic discoveries...
91 Views
Actionable Idea: Medgenics: Upcoming Catalyst, Recent Insider Buying, Huge Potential Market in ADHD.
We took another look at the design of the on-going phase 2/3 clinical trial for Medgenics Inc (MDGN US) NFC-1, to treat adolescents with attention...
574 Views
No more insights